Products - Chronic obstructive pulmonary disease | Topic | NICE

Showing 3 products

Date | Title

Status: Awaiting developmentRemove ‘Status: Awaiting development’ filter

Mepolizumab for reducing eosinophilic exacerbations of chronic obstructive pulmonary disease ID1237
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Astegolimab as add-on maintenance treatment for moderate to severe chronic obstructive pulmonary disease [ID6524]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Benralizumab to reduce exacerbations in moderate to very severe chronic obstructive pulmonary disease [ID1394]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC